Skip to content

Perianal Operating Scope Feasibliity

Perianal Operating Scope Feasibility

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02807792
Enrollment
0
Registered
2016-06-21
Start date
2017-07-31
Completion date
2018-07-31
Last updated
2017-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transanal Endoscopic Surgery

Keywords

Perianal surgery

Brief summary

This protocol will test a new prototype of a peri-anal access device, with increased flexible length and a captured operative field, for feasibility in patients immediately prior to their scheduled peri-anal procedure.

Detailed description

Research Methods: The insertion of the modified access device in five patients before their planned peri-anal procedure, which will subsequently be performed with standard instruments, will allow us to observe the ease of insertion, the expansion of the blades, and the creation of the operative field achieved. If necessary, we will modify our design based on these findings. When a successful, operating room prototype is established, the device will be suitable for clinical use and the stated benefits thereof.

Interventions

DEVICEPerianal access device

Perianal access device

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age range 18 to 80 * In good health status * Patients scheduled for a transanal procedure other than for anal lesions, e.g., hemorrhoids, fissures, abscesses

Exclusion criteria

* Patients with physical characteristics that distort the rectal sigmoid anatomy, e.g., spinal lesions. * Patients considerable unsuitable for inclusion in the study by their colorectal surgeon. * Patients considered too frail or ill by their physician to undergo a 5-10 minute prolongation of their procedure. * Patients with known rectosigmoid infections. * Patients with known rectosigmoid wall fragility. * Patients with known rectosigmoid perforations.

Design outcomes

Primary

MeasureTime frameDescription
Visual assessment of operative field dimensions measured in centimetersBaselineThe Outcome Measure Title implies the visual measurement that will be used to describe the potential operative field delineated by our experimental perianal access device. The description will, therefore, be primarily a qualitative visual assessment with the addition of estimated dimensions measured in centimeters for the length of the longitudinal and transverse fields encompassed by the blades of the access device. The collected measurement data will be aggregated, the numerical data averaged, and the visual perceptions integrated. The Time Frame for the individual study of each insertion will be two minutes or less. There is no chronic component to this feasibility analysis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026